help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S. C.
Right arrow Articles by Dickson, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S. C.
Right arrow Articles by Dickson, D. W.

American Journal of Pathology, Vol 148, 1267-1274, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis

SC Lee, A Casadevall and DW Dickson
Department of Pathology (Neuropathology), Albert Einstein College of Medicine, Bronx, New York 10401, USA.

Cryptococcal meningoencephalitis (CME) is caused by the encapsulated fungus Cryptococcus neoformans (CN) and is a major cause of mortality and morbidity in patients with AIDS. The polysaccharide capsule of CN is important for virulence, and soluble polysaccharide has the potential to cause immune modulation. To better understand the interactions of central nervous system cells and cryptococcal capsular polysaccharide (CNPS) in the pathogenesis of human CME, postmortem brain tissue from 21 patients with CME (13 AIDS and 8 non-AIDS patients) was analyzed. Histopathology and distribution of tissue CNPS antigen were analyzed using monoclonal antibodies against CNPS in combination with cell type-specific markers (glial fibrillary acidic protein for astrocytes, Ricinus communis agglutinin (RCA)-l for macrophage/microglia and endothelial cells; UCHL-1 for T cells, L26 for B cells). The CN cells showed discrete capsular immunoreactivity as expected; however, diffuse and particulate cellular and tissue staining for CNPS was detected in the brain parenchyma and the meninges in all cases. By quantitative analysis, the CNPS immunoreactive area ranged from 0.1 to 88 percent of tissue cross sectional area, and tended to be higher in brains of AIDS (median values from two sections ranged from 1 to 57 percent; mean, 26 percent) than in non-AIDS (0.1 to 40 percent; mean, 9.6 percent) patients. The proportion of CNPS immunoreactive area was positively correlated with the estimated number of CN. None (0/13) of the AIDS patients displayed significant inflammatory responses to CN, whereas most (7/8) non-AIDS patients showed granulomatous inflammatory responses. The phenotype of infiltrating lymphocytes was UCHL-1+/L26-/RC4-, thus consistent with activated T cells, both in AIDS and non-AIDS patients. Double immunolabeling studies revealed that tissue CNPS immunoreactivity was most often localized in macrophages and microglia, less frequently in reactive astrocytes and endothelial cells, but not in lymphocytes. This study demonstrates that CNPS can be detected not only in the serum and cerebrospinal fluid (CSF) of patients, but also in the affected tissue, most often localized in cells of mononuclear phagocyte system. Potential implications of these findings for the pathogenesis of CME are discussed.


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Monari, T. R. Kozel, F. Paganelli, E. Pericolini, S. Perito, F. Bistoni, A. Casadevall, and A. Vecchiarelli
Microbial Immune Suppression Mediated by Direct Engagement of Inhibitory Fc Receptor
J. Immunol., November 15, 2006; 177(10): 6842 - 6851.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. E. Yauch, M. K. Mansour, and S. M. Levitz
Receptor-Mediated Clearance of Cryptococcus neoformans Capsular Polysaccharide In Vivo
Infect. Immun., December 1, 2005; 73(12): 8429 - 8432.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. R. Martinez and A. Casadevall
Specific Antibody Can Prevent Fungal Biofilm Formation and This Effect Correlates with Protective Efficacy
Infect. Immun., October 1, 2005; 73(10): 6350 - 6362.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Shao, A. Mednick, M. Alvarez, N. van Rooijen, A. Casadevall, and D. L. Goldman
An Innate Immune System Cell Is a Major Determinant of Species-Related Susceptibility Differences to Fungal Pneumonia
J. Immunol., September 1, 2005; 175(5): 3244 - 3251.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. C. Fries, S. C. Lee, R. Kennan, W. Zhao, A. Casadevall, and D. L. Goldman
Phenotypic Switching of Cryptococcus neoformans Can Produce Variants That Elicit Increased Intracranial Pressure in a Rat Model of Cryptococcal Meningoencephalitis
Infect. Immun., March 1, 2005; 73(3): 1779 - 1787.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
B. R. Steen, S. Zuyderduyn, D. L. Toffaletti, M. Marra, S. J. M. Jones, J. R. Perfect, and J. Kronstad
Cryptococcus neoformans Gene Expression during Experimental Cryptococcal Meningitis
Eukaryot. Cell, December 1, 2003; 2(6): 1336 - 1349.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Shoham, C. Huang, J.-M. Chen, D. T. Golenbock, and S. M. Levitz
Toll-Like Receptor 4 Mediates Intracellular Signaling Without TNF-{{alpha}} Release in Response to Cryptococcus neoformans Polysaccharide Capsule
J. Immunol., April 1, 2001; 166(7): 4620 - 4626.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. Goldman, X. Song, R. Kitai, A. Casadevall, M.-L. Zhao, and S. C. Lee
Cryptococcus neoformans Induces Macrophage Inflammatory Protein 1{alpha} (MIP-1{alpha}) and MIP-1{beta} in Human Microglia: Role of Specific Antibody and Soluble Capsular Polysaccharide
Infect. Immun., March 1, 2001; 69(3): 1808 - 1815.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Lendvai, X.-W. Qu, W. Hsueh, and A. Casadevall
Mechanism for the Isotype Dependence of Antibody-Mediated Toxicity in Cryptococcus neoformans-Infected Mice
J. Immunol., April 15, 2000; 164(8): 4367 - 4374.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. L. Buchanan and H. A. Doyle
Requirement for CD4+ T Lymphocytes in Host Resistance against Cryptococcus neoformans in the Central Nervous System of Immunized Mice
Infect. Immun., February 1, 2000; 68(2): 456 - 462.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. M. Levitz, S.-H. Nong, K. F. Seetoo, T. S. Harrison, R. A. Speizer, and E. R. Simons
Cryptococcus neoformans Resides in an Acidic Phagolysosome of Human Macrophages
Infect. Immun., February 1, 1999; 67(2): 885 - 890.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Vecchiarelli, C. Retini, C. Monari, and A. Casadevall
Specific Antibody to Cryptococcus neoformans Alters Human Leukocyte Cytokine Synthesis and Promotes T-Cell Proliferation
Infect. Immun., March 1, 1998; 66(3): 1244 - 1247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.